SCHEMBL3929309

SCHEMBL3929309

C[Si](C)(C)CCOCn1nc2c(CCOC(=N)C(Cl)(Cl)Cl)cc(C(F)(F)F)cc2c1Br

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3923489 0.85 DGAT1 (0.38) DGAT1
SCHEMBL2426784 0.83 DGAT1 (0.34) DGAT1
SCHEMBL2425206 0.82 DGAT1 (0.39) DGAT1
SCHEMBL2423940 0.81 DGAT1 (0.40) DGAT1
SCHEMBL3937390 0.77 DGAT1 (0.33) DGAT1
SCHEMBL2425986 0.76 DGAT1 (0.38) DGAT1
SCHEMBL2429523 0.75 DGAT1 (0.35) DGAT1
SCHEMBL2425401 0.75 DGAT1 (0.38) DGAT1
SCHEMBL3923559 0.72
SCHEMBL3935350 0.71 TACR1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009009411-A1 SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-15 WO disclosed